F. Hoffmann-LaRoche Ltd.

FDA Regulatory Profile

F. Hoffmann-LaRoche Ltd. appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-105-2013, Class II) was initiated on September 5, 2012.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-105-2013Class IICymevene 500 mg Powder for Infusion, (ganciclovir), 50 mg/mL ganciclovir (reconstructed), Rx only, 1September 5, 2012